All In MedTech

FDA Clearance Tracker · P200049

Amplatzer™ Amulet™ Left Atrial Appendage Occluder

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Aug 14, 2021 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Aug 14, 2021

Approved

Time to decision

226 days

Received Dec 31, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P200049
Device name
Amplatzer™ Amulet™ Left Atrial Appendage Occluder
Applicant location
St. Paul, MN
Received
Dec 31, 2020
Decided
Aug 14, 2021
Decision
Approved
Supplements
19 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NGV

FDA's approval statement

As written in FDA's record.

Approval for The Amplatzer Amulet Left Atrial Appendage Occluder. The device is a percutaneous transcatheter device intended to reduce the risk of thrombus embolization from the left atrial appendage (LAA) in patients who have nonvalvular atrial fibrillation and who are at increased risk for stroke and systemic embolism based on CHADS2 or CHA2DS2-VASc scores, are suitable for short term anticoagulation therapy, and have appropriate rationale to seek a non-pharmacologic alternative to oral anticoagulation, taking into consideration the safety and effectiveness of the device.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NGV. The earliest in FDA's data is P130013, decided Mar 13, 2015.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.